Anticancer Therapies – Products

Characterization studies to be undertaken by the US National Cancer Institute’s Nanotechnology Characterization Laboratory.

This Technology Strategy Board-funded, government-backed assay performs significantly better than standard tests.

The 7th Annual Drug Discovery Conference is anticipated to attract over 1000 delegates, engaging scientists involved in early stage drug discovery.

New research shows that Bio-Rad’s Droplet Digital PCR (ddPCR™) technology can dramatically improve the sensitivity, precision, and throughput of a popular assay for telomerase activity.

Stanford University and Bio-Rad demonstrated that the QX100™ Droplet Digital PCR (ddPCR™) system enables accurate and precise measurements of cancer genome amplifications in archival cancer tissue samples.

Pamorelin® LA for the treatment of locally advanced or metastatic, hormone-dependent prostate cancer.

Ion chromatography method is sensitive, repeatable, and accurate.

Accurate and reliable risk stratification of early-stage patients for better-informed decisions regarding potentially life saving interventions.

New AgilePulse® MAX system offers the most advanced solution for large volume transfections by utilizing patented Pulse Agile™ technology.

Pricing commensurate with the assay's clinical value and consistent with other high-value, clinical assays.